February 15, 2013 (Vol. 33, No. 4)

Alan Burns, vp of quality management at Sartorius Stedium Biotech, was elected to the board of directors of Rx-360. This is an international pharmaceutical supply chain consortium. Burns has been appointed for a three-year term, together with six other individuals.

Alan Burns

Supernus Pharmaceuticals added Victor Vaughn as svp of sales…C. Russell Allen is now president and CEO at Georgia Bio…Oxyrane hired James Weston as vp of regulatory affairs and Susan Flint as executive director and head of clinical operations…Fluidigm named Gerhard F. Burbach to its board of directors…Todd G. Johnson joined Pathway Genomics as vp of sales and marketing…ICON added Robert L. Howie Jr. as CMO.

Aratana Therapeutics added Julia A. Stephanus as CCO. Prior to joining Aratana, Stephanus was director of the Companion Animal Global Franchise at Ceva Animal Health. She founded Summit VetPharm. Before that, Stephanus worked in sales and marketing positions for Pfizer.

Julia A. Stephanus

Ischemix hired David A. DeWahl Jr. as president and CEO…DiaMedica added Mark Robbins, Ph.D., as vp, clinical and regulatory affairs…Jonathan B. Lloyd Jones joined Columbia Laboratories as vp of finance and CFO…Divakar Ramakrishnan, Ph.D., is now svp of process development, manufacturing, and quality at Moderna…Aethlon Medical appointed Laszlo Radvanyi, Ph.D., to its scientific advisory board.

Henrik Björkman, Ph.D., is now chief technical officer and vp of technical affairs at Gyros. He joins Gyros from GE Healthcare Life Sciences, where he was most recently director, MicroCal R&D and senior integration manager. Formerly, Dr. Björkman was chief technology officer at Attana.

Henrik Björkman, Ph.D.

Seegene hired John G. Hurrell, Ph.D., as senior evp…Verastem promoted Robert Forrester to president…Probiodrug elected Ronald Black, M.D., as CMO and Inge Lues, Ph.D., as chief development officer…EndoGastric Solutions added Pat Crilly, Ph.D., as vp, human asset development and Lilip Lau as svp, R&D…Teresa DeHaemer joined Clinical Site Services as senior enrollment specialist…Joseph M. Marasco, Ph.D., is now president of Diffinity Genomics.

Roche hired John C. Reed, M.D., Ph.D., as head of pharma research and early development and as a member of the corporate executive committee. Formerly, he was CEO at Sanford-Burnham Medical Research Institute. He also has served on the boards of directors at several companies.

John C. Reed, M.D., Ph.D.

Global Virus Network appointed Kathleen Kennedy Townsend as chairperson and Lisa Paulsen, Romain Murenzi, G. Steven Burrill, Salim S. Abdool Karim, Andrew Cheng, Longde Wang, N. Scott Fine, Nicolas De Santis, and Raj Shah to its board of directors…Foundation Medicine hired Steven J. Kafka, Ph.D., as CBO…Bristol-Myers Squibb hired Mike Burgess, M.D., Ph.D., as svp, discovery medicine and clinical pharmacology…Novozymes hired Peder Holk Nielsen as president and CEO.

Send your People Announcements to [email protected]

Previous articleDon’t Want Cancer? Lay Off the Bottle
Next articleNewBridge to Commercialize Verinata’s Prenatal Test